TipRanks
Go Ultimate55% OFF

Edesa Biotech (EDSA) Income Statement

Edesa Biotech Income Statement

Last quarter (Q3 2026), Edesa Biotech's total revenue was $0.00. In Q3, Edesa Biotech's net income was $-5.41M. See Edesa Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementSep 25Sep 24Sep 23Sep 22Sep 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -119.27K$ 0.00$ 0.00$ 0.00$ -118.79K
$ 7.79M$ 7.01M$ 9.22M$ 18.37M$ 23.68M
Depreciation and Amortization$ 119.27K$ 186.05K$ 183.47K$ 118.19K$ 118.79K
$ -7.07M$ -6.13M$ -8.46M$ -17.47M$ -13.22M
$ -7.91M$ -7.01M$ -9.22M$ -18.37M$ -23.68M
$ 726.84K$ 845.50K$ 849.14K$ 822.67K$ 10.34M
$ -7.18M$ -6.17M$ -8.37M$ -17.55M$ -13.34M
$ -7.19M$ -6.17M$ -8.37M$ -17.55M$ -13.34M
Per Share Metrics
Basic EPS$ -1.27$ -1.93$ -2.93$ -8.37$ -7.74
Diluted EPS$ -1.27$ -1.93$ -2.93$ -8.37$ -7.73
Weighted Average Shares Outstanding5.68M3.20M2.86M2.10M1.73M
Weighted Average Shares Outstanding (Diluted)5.68M3.20M2.86M2.10M1.73M

Currency in USD

Edesa Biotech Earnings and Revenue History

-20M-10M010M-3000 %-2000 %-1000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin